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Abstract  
Mobile health (mHealth) has the potential to profoundly improve global healthcare delivery by enabling 
healthcare workers to make more accurate diagnoses, instantly access records and transmit data as well as 
allowing patients to take an active involvement in their own healthcare. However, this potential cannot be 
reached without the adequate evaluation of interventions to ensure that they are not only safe and 
beneficial, but that they are acceptable to end-users. A major challenge faced by emerging mHealth 
interventions is that of identifying an evaluation technique which is able to provide a thorough, rigorous 
evaluation, which incorporates the needs and requirements of all stakeholders. This investigation will 
compare four mHealth evaluation methodologies against the characteristics of mHealth across protocol-
related and logistical factors to identify methodological “matches” and to highlight important 
“mismatches.” These mismatches will require addressing in order to inform the design of the most 
rigorous and thorough mHealth evaluation protocol. 
Keywords  
mHealth (mobile health), evaluation, comparison. 
Introduction 
Mobile Health (mHealth) can be broadly defined as the use of mobile technologies like mobile phones, 
personal digital assistants, handheld and ultra-portable devices (tablets) and other mobile devices in 
healthcare to improve healthcare systems, support healthcare professionals and provide better health 
outcomes for patients (Burns, et al., 2016). In the past decade there has been an exponential increase in 
the number of mHealth applications available for use on mobile phones and tablets. There are currently 
165,000 health applications publicly available for download across Apple’s iOS and Google’s Android 
platforms (IMS Institute for Health Informatics, 2015). At present, there is no evaluation method which is 
specific to mHealth and there is little or no existing quality control or regulations to ensure these health 
apps are user-friendly, accurate in content, evidence-based or efficacious (Boudreaux, et al., 2014).  
There is very limited evidence on the effects of mHealth in low income countries and information on cost-
effectiveness of mHealth interventions is largely unavailable (Stephani, et al., 2016). Further, current 
research into the assessment of mHealth from the perspective of developing countries particularly with 
community health workers as the primary users tends to be limited (Tariq & Akter, 2011 In a healthcare 
system already burdened with suboptimal outcomes and excessive costs, premature adoption of untested 
mHealth technologies may detract from, rather than contribute to, what is needed for true overall health 
improvement (Kumar, et al., 2013). A further challenge to the evaluation of mHealth interventions lies in 
the subjectivity of evaluation; one may see an initiative as a success if most stakeholders attain their major 
goals and do not experience significant undesirable outcomes (Heeks, 2002). However, the stakeholders 
who do not attain their major goals may brand the initiative as a failure. To remedy this issue requires the 
relatively sophisticated approach to evaluation that is absent in most mHealth cases (Heeks, 2002). 
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Science cannot move as fast as new innovations hit the market but it may be the case that science may not 
necessarily match the pace as the goals of science and the industry are different (Pagoto & Bennett, 2013). 
Hatt, et al., (2015) believe that a rigorous mixed-methods approach is essential to untangle the “why” and 
the “how” of the impact identified in a RCT and that global public health practitioners should use the most 
rigorous systematic approach available to answer questions and make decisions in the face of uncertainty. 
In recent years, alternative evaluation methods for mHealth have begun appearing across the literature 
but they are as yet, unsuccessful in changing the perception that a RCT is the best mechanism for 
mHealth evaluation. Pham, et al., (2016) observed during their study that not once in the registration of 
any mHealth clinical trial were alternative methodologies to RCTs mentioned as more suitable for 
mHealth evaluation. 
This investigation will examine the classic RCT and newly emerging methods of mHealth evaluation; 
Continuous Evaluation of Evolving Behavioural Interventions Technologies (CEEBIT), Multiphase 
Optimisation Strategy (MOST) and Sequential Multiple Assignment Randomised Trial (SMART) outlining 
a comprehensive comparison between the characteristics of each trial design and the challenges posed by 
the unique field that is mHealth.  
Literature Review 
The current evidence for the efficacy of mHealth interventions is sparse due to a lack of appropriate 
evaluation frameworks (Kumar, et al., 2013; Hall, et al., 2014; Déglise, et al., 2012). A comprehensive 
review of the scope of mHealth in 2014 found only a 5-year history, which may partly explain why, in low- 
and middle-income countries, there remains a strong focus on mHealth pilot studies which have rarely 
been followed up with more rigorous evaluation studies and have generally not been taken to scale (Hall, 
et al., 2014). Although problems like chronic health conditions are key targets of emerging mHealth 
research, the hypothesis that better monitoring with mobile technology will lead to better management, 
better outcomes and reduced disease burden has yet to be adequately tested (Nilsen, et al., 2012). The 
evaluations that have been carried out on mHealth interventions often do not follow rigorous scientific 
standards of randomised controlled trials and consequently, they carry a relatively high risk of bias 
(Stephani, et al., 2016) and the current evidence is not convincing enough for policy-makers (Chib, et al., 
2014). Rigorous evaluation of mHealth apps is essential not only to estimate the magnitude of the 
outcomes but also to ensure that they do no harm (Pagoto & Bennett, 2013). Many health IT usability 
studies have been conducted to explore usability requirements, discover usability problems and design 
solutions, but few of these studies have evaluated the usability of mobile technologies (Brown III, et al., 
2013). The lack of evaluation across the mHealth field as a whole is a major weakness and threatens the 
credibility of mHealth as a concept (Hall, et al., 2014). Premature scale-up of a mHealth initiative could, 
due to early selection and failure of the wrong initiative, by extension, harm the entire field (Chib, et al., 
2014). The following sections descibe the different methods that are used to evaluate mHealth; RCT, 
CEEBIT, MOST and SMART methodologies. 
Randomised Controlled Trials 
The RCT is a trial in which subjects are randomly assigned to one of two groups: one (the experimental 
group) receiving the intervention that is being tested and the other (the comparison group or control) 
receiving an alternative (conventional or placebo) treatment (Kendall, 2003). All intervention groups are 
treated identically except for the experimental treatment (Sibbald & Roland, 1998). The two groups are 
then followed up to see if there are any differences between them in outcome. The results and subsequent 
analysis of the trial are used to assess the effectiveness of the intervention, which is the extent to which a 
treatment, procedure or service does more good than harm (Kendall, 2003). 
RCTs are considered to be the “gold standard” for examining the effectiveness of a medical interventions 
in a clinical domain due to their ability to control for confounding factors and bias (Kendall, 2003). Calls 
for greater rigor in evaluation has increased the number of mHealth RCTs conducted in developed and 
developing countries (Burns, et al., 2016). The overwhelming majority of mHealth researchers are 
continuing to use the RCT as the trial design of choice for evaluating mHealth apps. This suggests that 
researchers view this design to be condition-agnostic and truly the gold-standard for any clinical trial 
evaluating app efficacy (Pham, et al., 2016). 
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Continuous Evaluation of Evolving Behavioural Intervention Technologies  
Behavioural Intervention Technologies (BITs) are web-based and mobile interventions intended to 
support patients and consumers in changing behaviours related to health, mental health and well-being 
(Mohr, et al., 2013). CEEBIT is an evaluation method involving the deployment of substantively new 
versions of an intervention along with the previous version, with users randomised to available versions 
and the most efficacious version, based on a priori criteria, is retained (Kumar, et al., 2013). This 
framework was proposed by Mohr et al., as an alternative to the gold-standard RCT.  
This methodology addresses the current weak evidence base and lack of discussion addressing how to 
evaluate interventions, particularly BITs, effectively and efficiently and provides a solution to the 
challenge of rapid change, evolution and expanding expectations in the BIT market (Mohr, et al., 2013). 
This design may be well suited to ongoing evaluation of interventions as they go to scale, continuously 
improve over time and adapt to rapidly changing technologies (Kumar, et al., 2013).  The method is 
statistically powered to continuously evaluate application efficacy throughout trial duration and accounts 
for changing application versions through a sophisticated elimination process (Pham, et al., 2016). 
Multiphase Optimisation Strategy 
MOST uses a principled method for identifying which components are active in an intervention and which 
levels of each component lead to the best outcomes. Its underlying principles are drawn from engineering 
and emphasize efficiency (Collins, et al., 2007). Promising components of an intervention are identified in 
a screening phase through either factorial or fractional factorial analysis of variance design (Kumar, et al., 
2013). MOST uses three phases as a replacement for the cycle of confirmatory trial, exploratory analysis, 
revision and subsequent confirmatory trial (Collins, et al., 2005). The final, optimized intervention is then 
evaluated in a standard RCT in the confirming phase addressing whether the intervention is efficacious 
with a large enough effect to justify investment in a community implementation (Collins, et al., 2007). 
MOST is a system aimed at creating optimal versions of multicomponent interventions (Clough, et al., 
2015). The traditional approach to intervention development has involved constructing an intervention a 
priori and then evaluating it in a standard RCT, after which, post-hoc analyses are done and adjustments 
are made (Collins, et al., 2007).  
Sequential Multiple Assignment Randomised Trial 
The SMART approach is a randomised experimental design that has been developed especially for 
building time-varying adaptive interventions (Collins, et al., 2007). It allows investigators to evaluate the 
timing, sequencing, and adaptive selection of treatments in a principled fashion by use of randomised 
data (Almirall, et al., 2012). All questions within the SMART trial are addressed by means of randomised 
experiments and the end goal of the SMART approach is the development of evidence-based adaptive 
intervention strategies which are then evaluated in a subsequent RCT (Collins, et al., 2007). 
The SMART approach enables the intervention scientist to address questions about the intervention in a 
holistic yet rigorous manner, taking into account the order in which components are presented rather 
than considering each component in isolation (Collins, et al., 2007). Researchers decide which aspects of 
treatment require investigation and then individuals are randomly assigned to various intervention 
choices over time (Kumar, et al., 2013). With this approach, a number of important treatment questions 
can be answered; the optimal length of the intervention, the best approach to take for treatment of non-
responders and the level of support required for individuals (Clough, et al., 2015). It may be most 
advantageous to integrate a SMART trial into the MOST procedure during the refining phase, but SMART 
may also be used as a stand-alone technique (Collins, et al., 2007). 
Comparison of Evaluation Techniques 
The following table outlines the main characteristics of each evaluation technique in a comparison of their 
suitability to mHealth evaluation. These criteria have been determined as important in terms of choosing 
an evaluation technique as they examine both protocol-related factors, including standard execution and 
data collection techniques as well as logistical, resource requirement factors such as time and cost.  
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Quantitative analysis - The 
analysis is focused on estimating 
the size of difference in 
predefined outcomes (Sibbald & 
Roland, 1998). 
Collects outcome and use data in 
real time. CEEBIT capitalizes on 
data generates by BITs to 
continuously evaluate efficacy in 
a manner consistent with the 
current socio-technologic 
environment (Mohr, et al., 
2013). 
A key feature of MOST is that each new 
intervention produced will have been 
engineered, and empirically 
demonstrated, to be an improvement 
over the previous version (Collins, et al., 
2011). 
SMART designs provide a framework 
to empirically determine the most 
powerful version of an intervention 
(Clough, et al., 2015).  However, the 
SMART design does not compare the 
intervention to a control or 
comparative treatment condition 
(Clough, et al., 2015).   
mHealth literature suggests the need 
for mixed-method evaluation to 
accurately capture the socio-
technical reasons for using an 




Blinding - Double blinding 
(usually investigator and 
participants) is the usual 
standard and will eliminiate any 
confounding factors occuring 
after randomisation (Kendall, 
2003). 
In instances when non-
randomised assignment 
methods are warranted, 
statistical methods can mitigate 
overt bias when all confounding 
factors are observed (Mohr, et 
al., 2013). 
Based on randomised experimentation, 
meaning that a high degree of 
confidence can be placed on the results 
(Collins, et al., 2007). 
 
Based on randomised experimentation, 
placing a high degree of confidence on 
the results (Collins, et al., 2007). To 
avoid information bias, the use of a 
blinded, independent evaluator is 
suggested (Almirall, et al., 2014). 
It is difficult to blind participants 
receiving an mHealth intervention 
due to the physical presence of the 




The sample size must be large 
enough to eliminate chance 
(Kendall, 2003). 
The sample size required in a 
CEEBIT methodology is 
considerably reduced due to a 
more liberal Type I error rate of 
50% (Mohr, et al., 2013). 
Interaction effect sizes tend to be small, 
making it important to ensure that there 
is sufficient statistical power to test any 
interactions that are of particular 
interest (Collins, et al., 2007). 
The sample size required will depend 
on the primary aim for the trial and the 
level of analyses. In a longitudinal 
comparison of two groups, the sample 
size requirement is identical to that of a 
two-group, longitudinal RCT (Almirall, 
et al., 2014).  
Recruiting adequate numbers may 
be challenging in developing 
countries where cultural and 
religious barriers may resist 
technological change (Tariq & Akter, 
2011). 
Cost RCTs are expensive to carry out 
(Comstock, 2012) often due to 
the large sample size and length 
of follow-up time required 
(Rosen, et al., 2006).  
The reduced sample size and 
rapid, real-time evaluation may 
contribute to lower financial 
costs than other methodologies. 
MOST does not directly assess the 
overall effectiveness of the intervention 
to a comparative treatment or control 
condition but the process does ensure 
that the most efficacious version of the 
intervention goes forward to the final 
testing stage, thereby making for a more 
efficient use of time and resources 
(Clough, et al., 2015). 
It would be more cost-effective both in 
terms of dollars spent, and in terms of 
the value of scientific information 
gained to use the SMART methodology, 
than to use a RCT to evaluate each 
question in the SMART stages 
(Almirall, et al., 2014). 
In low-income countries where there 
may not be the resources to carry out 
expensive trials (Rosen, et al., 2006; 
World Health Organisation, 2012) 
and also in high-income countries 
where the sheer volume of mHealth 
interventions available, may mean it 
is not feasable to carry out resource-
intensive evaluations. 
Protocol Rigid protocol, designed for the 
elimination of bias and 
confounding factors (Pham, et 
al., 2016). 
Protocol is fluid, allowing for 
consumer choice to be 
incorporated into the evaluation 
as a fully observed pre-
randomisation factor (Mohr, et 
al., 2013). 
Protocol is fluid, exact details about its 
implementation depend on the 
application (Collins, et al., 2007). It is a 
“general approach,” rather than an off-
the-shelf procedure (Collins, et al., 
2011). 
SMART designs are not, as per 
common misconceptions, “adaptive 
trial designs,” they are a fixed study 
design. (Almirall, et al., 2014, Almirall, 
et al., 2012). 
Software is meant to evolve, change 
and progress over time at a rapid 
pace  (Ben-Zeev, et al., 2015). 
Time RCTs are notoriously long 
(Pham, et al., 2016), with the 
entire process, including funding 
proposals and publication, 
taking upto 17 years (Pagoto & 
Bennett, 2013; Mohr, et al., 
2013). 
CEEBIT can support the rapid 
evaluation of BITs in near-real 
time through deployment sites 
located in care-providing 
organisations or commercial 
market places with the aim of 
protecting consumers from 
ineffective or inferior BITs 
(Mohr, et al., 2013).  
A challenge is whether a full cycle of 
MOST can be completed within the five-
year duration of the typical National 
Institutes of Health (NIH) funding cycle 
(Collins, et al., 2011). 
The overarching aim of a SMART is to 
construct a high quality adaptive 
intervention based on data (Almirall, et 
al., 2014). This may save resources in 
the long run as the end intervention 
will be already optimised. 
In the mHealth field, the fast pace at 
which technology evolves, may make 
lengthy study designs unsuitable for 
evaluation as in the time it takes to 
design and evaluate an intervention, 
the mHealth space may move so fast 
that the intervention is obsolete 
before it has even been implemented  
(Kumar, et al., 2013). 
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Discussion 
As outlined in the table above, a number of factors must be taken into account when selecting an 
evaluation method for a mHealth intervention. The mHealth literature widely suggests that a mixed-
methods approach should be used when evaluating a mHealth intervention. Quantitative data is 
important to determine if, and to what extent an intervention is functional and beneficial, but because of 
the many socio-technical aspects of mHealth, failing to include a qualitative evaluation may mean that the 
intervention will fail to be implemented. These sociotechnical factors include the social, cultural, religious 
and behavioural interactions of the end user, as well as other technological issues (Chib, et al., 2014), such 
as adequate cellular service and charging points, an issue which is particularly important in low- and 
middle- income countries. A RCT in its pure state immediately highlights an issue as its data collection 
and analysis is purely quantitative, meaning a standard RCT is unable to isolate the socio-technical 
aspects of mHealth which are so important for their successful implementation. The inclusion/exclusion 
criteria employed in RCTs can at times lead to high levels of internal validity but poor external validity 
when programs are eventually deployed in community settings (Clough, et al., 2015). The CEEBIT method 
has the potential to include a qualitative aspect but the selection of outcome measures will depend on 
whether the research question primarily pertains to the efficacy or the effectiveness of the app (Clough, et 
al., 2015). However, if a researcher is primarily concerned with the efficacy of an app, it could be possible 
that a qualitative evaluation will be absent and compromise the implementation of the intervention. 
Similarly, the MOST method consists of three phases, each of which addresses a different set of questions 
about the intervention by means of randomised, quantitative experiment and ending with the optimised 
intervention being evaluated in a RCT. Although the SMART trial follows a quantitative methodology, the 
pilot SMART trial can include qualitative aspects such as focus groups or structured exit interviews to 
help uncover new and potentially important tailoring variables (Almirall, et al., 2012). 
All methodologies outlined in the table above include randomisation to eliminate certain biases and 
confounding factors, as well as allowing confidence to be placed on the results. The randomisations in 
SMART are aimed at permitting unbiased comparisons between treatment components (or their levels) at 
each decision stage in the development of adaptive interventions (Almirall, et al., 2014). As outlined, there 
is a difficulty in blinding recipients of a mHealth intervention due to the physical presence of the device 
but the SMART trial suggests the use of an independent evaluator who is blind to treatment assignment to 
eliminate any information bias which may result (Almirall, et al., 2014). This is important because a lack 
of blinding in a study design could lead to an over-estimation of the effects of an intervention, as was 
illustrated by Colditz, et al., (1989) who found that medical interventions evaluated within randomised 
trials that did not use a double-blind design reported a significantly greater likelihood of success on 
average than the studies that used double blinding.  
A large sample size may be problematic in the area of mHealth, particularly in low- and middle-income 
countries where there may be cultural and religious barriers to technology, resisting change and creating 
challenges with recruitment (Tariq, et al., 2011) as well as technological barriers which may prevent usage 
such as intermittent reception and unreliable electricity for charging of devices. RCTs require a relatively 
large sample size in order to eliminate chance (Kendall, 2003), MOST requires a large enough sample size 
to detect small variations in interaction effects with sufficient statistical power (Collins, et al., 2007) and 
SMART claims to require a sample size similar to that of a RCT (Almirall, et al., 2014). However, CEEBIT 
claims to require a much smaller sample size due to it’s much more liberal Type 1 error rate of 50%, 
compared to the standard Type 1 error rate of 5%.  
RCTs are notoriously expensive (Comstock, 2012), rendering them potentially unsuitable for a low- and 
middle-income countries where financial resources are scarce (Rosen, et al., 2006; World Health 
Organisation, 2012), or even in a developed country, given the sheer volume of mHealth tools and 
applications currently requiring evaluation, as outlined earlier. The MOST and SMART methodologies 
both suggest greater cost-effectiveness than RCTs in that they are ensuring that the most efficient, fully 
optimised version of the app is going forward to be tested in a RCT (Almirall, et al., 2012, Clough, et al., 
2015). The use of MOST does not require more resources than the classical approach, just a realignment 
of resources (Kugler, et al., 2016). Although it could be argued that because these methodologies still 
require RCT evaluation, they are equally as expensive, the proponents of these methodologies argue that 
the typical cycle of intervention-RCT-post hoc analyses-revision of intervention-RCT is likely to lead very 
slowly, if at all to an optimised intervention (Collins, et al., 2007). By presenting an already-optimised 
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intervention for RCT, both financial and time resources can be saved because the traditional RCT 
evaluates the intervention only as a whole, using the RCT alone does not enable isolation of the effects of 
individual program or delivery components (Collins, et al., 2007). The SMART design differs considerably 
from standard RCTs in terms of their overarching aim. Whereas the overarching aim of a SMART is to 
construct a high quality adaptive intervention based on data, the overarching aim of a RCT is to evaluate 
an already developed interventions versus a suitable control (Almirall, et al., 2014). 
Timing is critical in the evaluation of mHealth interventions, given how fast technology evolves and 
develops, with a mere decade bringing exponential growth and change to the field. In the typically lengthy 
process of a RCT, a mHealth intervention may become obsolete in the time it takes to evaluate it. The 
CEEBIT methodology deals with this issue well, evaluating interventions in near real-time through 
deployment sites located in care providing organisations (Mohr, et al., 2013). The MOST methodology 
faces challenges as to whether a full cycle can be completed within the typical National Institute of Health 
(NIH) funding cycle (Collins, et al., 2011). Although, as Collins, et al., (2011) argue, this five-year funding 
cycle is merely an administrative necessity with no intrinsic scientific meaning or merit, it may still be 
incompatible with the speed at which the field of mHealth develops, as mentioned previously, a relatively 
short period of time in the context of drug development and trialing equates to a very long period of time 
in the mHealth field and the MOST methodology may be, similarly to the RCT, regarded as too long for 
mHealth. 
Conclusion 
As outlined by White, et al., (2016), to determine the success of a mHealth intervention, evaluation should 
examine user feedback and outcome measures, as well as the robustness of the technology, the 
intervention principles, engagement strategies and the interaction of the user with the technology. The 
comparison of the RCT, CEEBIT, MOST and SMART methodologies shows that each is capable of 
examining a number of these factors. However, it is apparent that the methodologies discussed are unable 
to examine all elements simultaneously and within the strict time constraints imposed by the rapidly 
evolving field of mHealth. There is a need for further research into the area of mHealth evaluation to build 
upon the methodologies currently available for mHealth interventions. The mis-matches between the 
mHealth criteria and the evaluation methodologies must be addressed to allow for the development of a 
holistic evaluation approach that will allow evaluations of mHealth interventions to provide the most 
robust and thorough results and contribute to timely, successful and long-term mHealth 
implementations. This investigation has limitations; the evaluation methodologies have been described in 
their simplest, pure state and the observations made apply only to those. Evaluation methodologies are 
adapted to suit the context in which they are being carried out and these context-dependent adaptations 
have not been taken into account in the above comparison; due to time constraints, it was possible to 
examine only the most common evaluation methodologies and it is possible that this comparison of 
evaluation methodologies against mHealth criteria is not exhaustive. Further investigation should 
examine the contextual adaptations applied to the RCT, CEEBIT, MOST and SMART methodologies and 
the potential of these adaptations to produce a better “fit” for mHealth evaluation.  
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